![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Review of Leishmaniasis Treatment: Can We See the Forest through the Trees?
Moshe Shmueli, Shalom Ben‐Shimol
Pharmacy (2024) Vol. 12, Iss. 1, pp. 30-30
Open Access | Times Cited: 15
Moshe Shmueli, Shalom Ben‐Shimol
Pharmacy (2024) Vol. 12, Iss. 1, pp. 30-30
Open Access | Times Cited: 15
Showing 15 citing articles:
Ritonavir enhances the efficacy of amprenavir: A promising combination therapy by targeting Leishmania DNA topoisomerase I for treatment of visceral leishmaniasis
Priyanka H. Mazire, Snehal Shingade, Amit Roy
Experimental Parasitology (2025) Vol. 269, pp. 108898-108898
Closed Access
Priyanka H. Mazire, Snehal Shingade, Amit Roy
Experimental Parasitology (2025) Vol. 269, pp. 108898-108898
Closed Access
Synthesis and evaluation of nitrochromene derivatives as potential antileishmanial therapeutics through biological and computational studies
Naeme Javid, Ali Asadipour, Ehsan Salarkia, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Naeme Javid, Ali Asadipour, Ehsan Salarkia, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Molecular Mechanisms of Drug Resistance in Leishmania spp.
María Juliana Moncada-Díaz, Cristian Camilo Rodríguez-Almonacid, Eyson Quiceno-Giraldo, et al.
Pathogens (2024) Vol. 13, Iss. 10, pp. 835-835
Open Access | Times Cited: 5
María Juliana Moncada-Díaz, Cristian Camilo Rodríguez-Almonacid, Eyson Quiceno-Giraldo, et al.
Pathogens (2024) Vol. 13, Iss. 10, pp. 835-835
Open Access | Times Cited: 5
Discovery of 8-hydroxy-2-quinoline carbaldehyde derivatives as inhibitors for M1 aminopeptidase of Leishmania donovani
Janish Kumar, Jyotisha, Rahila Qureshi, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135105-135105
Closed Access | Times Cited: 3
Janish Kumar, Jyotisha, Rahila Qureshi, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135105-135105
Closed Access | Times Cited: 3
Compared Antileishmanial Activity of Clomiphene and Tamoxifen
Sergio Sifontes, Alma Reyna Escalona‐Montaño, Ricardo Mondragón‐Flores, et al.
(2024)
Open Access | Times Cited: 1
Sergio Sifontes, Alma Reyna Escalona‐Montaño, Ricardo Mondragón‐Flores, et al.
(2024)
Open Access | Times Cited: 1
Efficacy of Diterpene Polyalthic Acid Combined with Amphotericin B against Leishmania amazonensis In Vitro
Ana Carolina Bolela Bovo Cândido, Mariana Cintra Pagotti, Daiane Albino dos Santos, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1243-1243
Open Access | Times Cited: 1
Ana Carolina Bolela Bovo Cândido, Mariana Cintra Pagotti, Daiane Albino dos Santos, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1243-1243
Open Access | Times Cited: 1
Recent advances in antileishmanial drugs: New leishmaniasis medicine through repurposing approach
Lon‐Fye Lye, Chin-Fu Lin, Yen‐Chuan Ou, et al.
童綜合醫學雜誌 (2024) Vol. 18, Iss. Suppl 1, pp. S1-S5
Open Access
Lon‐Fye Lye, Chin-Fu Lin, Yen‐Chuan Ou, et al.
童綜合醫學雜誌 (2024) Vol. 18, Iss. Suppl 1, pp. S1-S5
Open Access
Instrument-Free Point-of-Care Diagnostic for Leishmania Parasites
Taralyn J. Wiggins, Ruonan Peng, Ruth V. Bushnell, et al.
Diagnostics (2024) Vol. 14, Iss. 23, pp. 2744-2744
Open Access
Taralyn J. Wiggins, Ruonan Peng, Ruth V. Bushnell, et al.
Diagnostics (2024) Vol. 14, Iss. 23, pp. 2744-2744
Open Access
Biological Evaluation of 3-Aryl and/or 4-(N-Aryl)aminocoumarins Against Human Pathogens: Antileishmanial and Antiviral Activities
Vitor Won‐Held Rabelo, Leonardo S. A. Carneiro, Luan Letieri Belem Martins, et al.
Future Pharmacology (2024) Vol. 4, Iss. 4, pp. 919-933
Open Access
Vitor Won‐Held Rabelo, Leonardo S. A. Carneiro, Luan Letieri Belem Martins, et al.
Future Pharmacology (2024) Vol. 4, Iss. 4, pp. 919-933
Open Access
Amprenavir-Ritonavir Combination Is More Effective in Leishmania donovani Compared to Leishmania major
Amit Roy
(2024), pp. 35-44
Closed Access
Amit Roy
(2024), pp. 35-44
Closed Access
Proposal of a topical alternative for Cutaneous Leishmaniasis
Lilian Sosa, María Rincón
Bionatura journal : (2024) Vol. 1, Iss. 1, pp. 1-5
Open Access
Lilian Sosa, María Rincón
Bionatura journal : (2024) Vol. 1, Iss. 1, pp. 1-5
Open Access
Spectrum of bacterial pathogens in inflammatory and noninflammatory cutaneous ulcers of American tegumentary leishmaniasis
Ruwandi Kariyawasam, Bryan Gascon, Priyanka Challa, et al.
Therapeutic Advances in Infectious Disease (2024) Vol. 11
Open Access
Ruwandi Kariyawasam, Bryan Gascon, Priyanka Challa, et al.
Therapeutic Advances in Infectious Disease (2024) Vol. 11
Open Access
Compared Antileishmanial Activity of Clomiphene and Tamoxifen
Sergio Sifontes, Alma Reyna Escalona‐Montaño, Ricardo Mondragón‐Flores, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2290-2290
Open Access
Sergio Sifontes, Alma Reyna Escalona‐Montaño, Ricardo Mondragón‐Flores, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2290-2290
Open Access
Proposal of a topical alternative for Cutaneous Leishmaniasis
Lilian Sosa, María Rincón
Bionatura journal : (2024) Vol. 1, Iss. 1, pp. 1-4
Closed Access
Lilian Sosa, María Rincón
Bionatura journal : (2024) Vol. 1, Iss. 1, pp. 1-4
Closed Access
In Silico Study of FDA-Approved Drugs on Leishmania infantum CYP51, a Drug Repositioning Approach in Visceral Leishmaniasis
Juan Diego Guarimata, Martín J. Lavecchia
(2024), pp. 11-11
Open Access
Juan Diego Guarimata, Martín J. Lavecchia
(2024), pp. 11-11
Open Access